FDA Inspection
FUJIFILM Diosynth Biotechnologies UK LimitedFUJIFILM Diosynth Biotechnologies UK Limited – FDA Inspection, Mar 17, 2023
Record Details
This FDA Inspection record concerns FUJIFILM Diosynth Biotechnologies UK Limited, with an inspection on March 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4d6a78ce-42f0-4143-ab86-759495398523
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200417
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of FUJIFILM Diosynth Biotechnologies UK Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 1, 2026 | Not classified | Office of Inspections and Investigations | |
| March 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2018 | Not classified | Office of Inspections and Investigations | |
| July 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for FUJIFILM Diosynth Biotechnologies UK Limited
- FDA Inspection 1339338 - 2026-09-01
- FDA Inspection 1155694 - 2021-03-25
- FDA Inspection 1097949 - 2018-11-16
- FDA Inspection 894612 - 2014-07-11
- FDA Inspection 790405 - 2012-06-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.